Physician profile
Timothy Ryan
NPI 1821389842
$2,222.61
in general payments reported to CMS, 2019-2025
20 companies · $574 in 2025
The $574 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $129 · 2020: $119 · 2021: $33.17 · 2022: $381 · 2023: $351 · 2024: $636 · 2025: $574.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,561.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,560.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Karl Storz Endoscopy-America | $609.00 | 2021-2025 | Tele Pack, N.A. |
| Medtronic, INC. | $408.07 | 2021-2025 | Nim Vital, Pteye Parathyroid Detection System, Sinuva |
| Aerin Medical INC. | $344.29 | 2020-2024 | |
| Inspire Medical Systems, INC. | $270.50 | 2025 | Inspire |
| Genzyme Corporation | $93.67 | 2020-2025 | |
| Neurent Medical Limited | $84.17 | 2023 | Neuromark Radiofrequency Console, Neuromark Device |
| Stryker Corporation | $73.93 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $48.89 | 2019-2020 | |
| Acclarent, INC | $44.07 | 2022-2023 | Acclarent Balloon Inflation Device |
| Merck Sharp & Dohme LLC | $37.51 | 2020-2023 | |
| Medtronic USA, INC. | $31.24 | 2019 | |
| Janssen Pharmaceuticals, INC | $30.28 | 2023 | Xarelto |
| Novartis Pharmaceuticals Corporation | $28.71 | 2023 | |
| Ambu INC. | $23.67 | 2020 | |
| Tesaro, INC. | $21.67 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $17.32 | 2025 | Nucala |
| Cochlear Americas | $15.24 | 2019 | |
| Smith+Nephew, INC. | $14.61 | 2024 | Tula |
| Janssen Biotech, INC. | $13.10 | 2022 | |
| Seagen INC. | $12.67 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Ryan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.